| Dr Veetai Li, MD | |
|
1001 Main St Fl 3, Buffalo, NY 14203-1009 | |
| (716) 878-7386 | |
| (716) 878-1577 |
| Full Name | Dr Veetai Li |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 40 Years |
| Location | 1001 Main St Fl 3, Buffalo, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073582243 | NPI | - | NPPES |
| 01440133 | Medicaid | NY | |
| 000511958002 | Other | NY | BLUE CROSS WNY |
| 00010104202 | Other | NY | UNIVERA |
| 0605545 | Other | NY | INDEPENDENT HEALTH INS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 193028 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaleida Health | Buffalo, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University At Buffalo Neurosurgery Inc | 0143124719 | 58 |
News Archive
Dyax Corp. announced today that the European Medicines Agency (EMA) has completed its validation process for the Marketing Authorization Application (MAA) for potential approval to market DX-88 (ecallantide) in the European Union (EU).
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Quetiapine Fumarate Tablets, 25 mg.
Caloric restriction diets have been associated with various health benefits, but their effects on the skin have not been previously demonstrated. Research conducted at the University of São Paulo (USP) in Brazil shows that controlling calories helps mice live longer, although it reduces the reserves of fat in adipose tissue needed to keep the body warm.
Journalism researchers criticized media coverage of the health care bills saying it may have added to consumers' confusion, Health News Florida reports. "Very little broadcast time or print space has been devoted to explaining, point-by-point, the major parts of the legislation, say three top researchers in the field from University of Florida, Florida State University and University of South Florida.
Mymetics Corporation, a pioneer in the research and development of virosome-based vaccines to prevent transmission of human infectious diseases across mucosal membranes, announced today that its innovative HIV vaccine candidate will enter a new preclinical trial to confirm excellent results obtained in a previous trial.
› Verified 3 days ago
| Entity Name | Kaleida Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366473183 PECOS PAC ID: 7810805280 Enrollment ID: O20031105000212 |
News Archive
Dyax Corp. announced today that the European Medicines Agency (EMA) has completed its validation process for the Marketing Authorization Application (MAA) for potential approval to market DX-88 (ecallantide) in the European Union (EU).
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Quetiapine Fumarate Tablets, 25 mg.
Caloric restriction diets have been associated with various health benefits, but their effects on the skin have not been previously demonstrated. Research conducted at the University of São Paulo (USP) in Brazil shows that controlling calories helps mice live longer, although it reduces the reserves of fat in adipose tissue needed to keep the body warm.
Journalism researchers criticized media coverage of the health care bills saying it may have added to consumers' confusion, Health News Florida reports. "Very little broadcast time or print space has been devoted to explaining, point-by-point, the major parts of the legislation, say three top researchers in the field from University of Florida, Florida State University and University of South Florida.
Mymetics Corporation, a pioneer in the research and development of virosome-based vaccines to prevent transmission of human infectious diseases across mucosal membranes, announced today that its innovative HIV vaccine candidate will enter a new preclinical trial to confirm excellent results obtained in a previous trial.
› Verified 3 days ago
| Entity Name | University At Buffalo Neurosurgery Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306896220 PECOS PAC ID: 0143124719 Enrollment ID: O20031125000264 |
News Archive
Dyax Corp. announced today that the European Medicines Agency (EMA) has completed its validation process for the Marketing Authorization Application (MAA) for potential approval to market DX-88 (ecallantide) in the European Union (EU).
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Quetiapine Fumarate Tablets, 25 mg.
Caloric restriction diets have been associated with various health benefits, but their effects on the skin have not been previously demonstrated. Research conducted at the University of São Paulo (USP) in Brazil shows that controlling calories helps mice live longer, although it reduces the reserves of fat in adipose tissue needed to keep the body warm.
Journalism researchers criticized media coverage of the health care bills saying it may have added to consumers' confusion, Health News Florida reports. "Very little broadcast time or print space has been devoted to explaining, point-by-point, the major parts of the legislation, say three top researchers in the field from University of Florida, Florida State University and University of South Florida.
Mymetics Corporation, a pioneer in the research and development of virosome-based vaccines to prevent transmission of human infectious diseases across mucosal membranes, announced today that its innovative HIV vaccine candidate will enter a new preclinical trial to confirm excellent results obtained in a previous trial.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Veetai Li, MD 1001 Main St Fl 3, Buffalo, NY 14203-1009 Ph: (716) 878-7386 | Dr Veetai Li, MD 1001 Main St Fl 3, Buffalo, NY 14203-1009 Ph: (716) 878-7386 |
News Archive
Dyax Corp. announced today that the European Medicines Agency (EMA) has completed its validation process for the Marketing Authorization Application (MAA) for potential approval to market DX-88 (ecallantide) in the European Union (EU).
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Quetiapine Fumarate Tablets, 25 mg.
Caloric restriction diets have been associated with various health benefits, but their effects on the skin have not been previously demonstrated. Research conducted at the University of São Paulo (USP) in Brazil shows that controlling calories helps mice live longer, although it reduces the reserves of fat in adipose tissue needed to keep the body warm.
Journalism researchers criticized media coverage of the health care bills saying it may have added to consumers' confusion, Health News Florida reports. "Very little broadcast time or print space has been devoted to explaining, point-by-point, the major parts of the legislation, say three top researchers in the field from University of Florida, Florida State University and University of South Florida.
Mymetics Corporation, a pioneer in the research and development of virosome-based vaccines to prevent transmission of human infectious diseases across mucosal membranes, announced today that its innovative HIV vaccine candidate will enter a new preclinical trial to confirm excellent results obtained in a previous trial.
› Verified 3 days ago
Dr. Kevin J Gibbons, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 High St, Suite B4, Buffalo, NY 14203 Phone: 716-218-1000 Fax: 716-650-2691 | |
Andrew Joseph Fabiano, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: Elm And Carlton Streets, Buffalo, NY 14263 Phone: 716-845-2300 Fax: 716-845-8980 | |
Dr. Jason Michael Davies, M.D., PH.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 High St, Suite B-4, Buffalo, NY 14203 Phone: 716-218-1000 Fax: 716-859-7480 | |
Dr. Pui Man Rosalind Lai, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 40 George Karl Blvd Ste 200, Buffalo, NY 14221 Phone: 716-218-1000 | |
Robert Fenstermaker, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: Elm And Carlton Streets, Buffalo, NY 14263 Phone: 716-845-2300 Fax: 716-845-8980 | |
Lindsay Lipinski, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: Elm And Carlton Streets, Buffalo, NY 14263 Phone: 716-845-2300 |